Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;112(1):78-88.
doi: 10.1002/jcb.22770.

Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells

Affiliations

Down-regulation of Notch-1 is associated with Akt and FoxM1 in inducing cell growth inhibition and apoptosis in prostate cancer cells

Zhiwei Wang et al. J Cell Biochem. 2011 Jan.

Retraction in

Abstract

Although many studies have been done to uncover the mechanisms by which down-regulation of Notch-1 exerts its anti-tumor activity against a variety of human malignancies, the precise molecular mechanisms remain unclear. In the present study, we investigated the cellular consequence of Notch-1 down-regulation and also assessed the molecular consequence of Notch-1-mediated alterations of its downstream targets on cell viability and apoptosis in prostate cancer (PCa) cells. We found that the down-regulation of Notch-1 led to the inhibition of cell growth and induction of apoptosis, which was mechanistically linked with down-regulation of Akt and FoxM1, suggesting for the first time that Akt and FoxM1 are downstream targets of Notch-1 signaling. Moreover, we found that a "natural agent" (genistein) originally discovered from soybean could cause significant reduction in cell viability and induced apoptosis of PCa cells, which was consistent with down-regulation of Notch-1, Akt, and FoxM1. These results suggest that down-regulation of Notch-1 by novel agents could become a newer approach for the prevention of tumor progression and/or treatment, which is likely to be mediated via inactivation of Akt and FoxM1 signaling pathways in PCa.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Notch signaling pathway in PCa cell lines. The baseline expression of Notch signaling pathway was determined in a panel of PCa cell lines using real-time RT-PCR (A,C) and Western blotting analysis (B,D), respectively.
Fig. 2
Fig. 2
Down-regulation of Akt inhibited FoxM1. A: The baseline expression of FoxM1 was determined between a panel of PCa cell lines using real-time RT-PCR and Western blotting analysis, respectively. B: Down-regulation of Akt by siRNA inhibited FoxM1 expression, whereas up-regulation of Akt by cDNA plasmid transfection resulted in increased expression of FoxM1. Akt siRNA inhibited cell growth, while Akt cDNA transfection promoted cell growth. C: Inactivation of Akt by PI3K inhibitors (LY294002, Wortmanin) inhibited the expression of pAkt, which was consistent with decreased expression of FoxM1 as assessed by Western blot analysis.
Fig. 3
Fig. 3
Inhibition of FoxM1 expression by Notch-1 siRNA and GSI. A: The expression of FoxM1 was detected by Western blotting analysis (left panel) and real-time RT-PCR (right panel) in PCa cells transfected with Notch-1 siRNA. B: The expression of FoxM1 was detected by Western blotting analysis in PCa cells treated with GSI for 72 h. C: The expression of FoxM1 was detected by real-time RT-PCR (left panel) and Western blotting analysis (right panel) in PC-3 ICN cells. D: The PC-3 and PC-3 ICN cells were subjected to immunofluorescent staining using anti-FoxM1 antibody. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Fig. 4
Fig. 4
Inhibition of Notch, Akt, and FoxM1 expression by genistein. A: PCa cells were treated with varied concentrations of genistein for 72 h. Left panel: The expression of Notch, pAkt, and FoxM1 protein was detected by Western blotting analysis. Middle and right panel: Notch-1 mRNA and FoxM1 mRNA were detected by real-time RT-PCR. B: Immunofluorescent staining showing lower levels of FoxM1 protein in the cytoplasm and nucleus in the genistein-treated PC-3 cells. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Fig. 5
Fig. 5
Down-regulation of Notch-1 by siRNA promotes genistein-induced cell growth inhibition and apoptosis in PC-3 cells. Genistein: 30 µM genistein; NS: Notch-1 siRNA; ICN: ICN cDNA; genistein+siRNA: 30 mM genistein+Notch-1 siRNA; genistein +ICN: 30 mM genistein+ ICN cDNA. A: Left panel: Down-regulation of Notch-1 by siRNA significantly inhibited PC-3 cell growth. Genistein plus Notch-1 siRNA inhibited cell growth to a greater degree compared to genistein alone. Right panel: Down-regulation of Notch-1 expression significantly increased apoptosis induced by genistein. Notch-1 siRNA-transfected cells were significantly more sensitive to spontaneous and genistein-induced apoptosis. B: Over-expression of Notch-1 expression significantly promoted cell growth. Over-expression of Notch-1 rescued cells from genistein-induced cell growth inhibition. Over-expression of Notch-1 by Notch-1 cDNA transfection abrogated genistein-induced apoptosis to a certain degree. C: The expression of FoxM1 was detected by Western blotting analysis in PCa cells treated with different concentrations of taxotere for 72 h. D: Left panel: Genistein synergize with taxotere leading to enhanced suppression of cell growth as assessed by MTT assay. Right panel: Genistein combined with taxotere led to synergistic induction of apoptotic cell death.
Fig. 6
Fig. 6
Genistein inhibited tumor growth in animal model. A: Inhibitory effects of genistein on the growth of tumors formed by PC-3 or C4-2B cells in SCID-human mice (control, n = 7; genistein, n = 7). Comparison of the tumor volumes in each group on the day when all mice were sacrificed (*P < 0.05, genistein vs. control). B: Genistein inhibited the expression of Notch-1, pAkt, and FoxM1 in tumor remnants as assessed by Western blot analysis. C: The schematic presentation of our proposed mechanism of how genistein inhibits cell growth and induces apoptosis.

Similar articles

Cited by

References

    1. Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res. 2005;65:9064–9072. - PubMed
    1. Banerjee S, Hussain M, Wang Z, Saliganan A, Che M, Bonfil D, Cher M, Sarkar FH. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer. Cancer Res. 2007a;67:3818–3826. - PubMed
    1. Banerjee S, Zhang Y, Wang Z, Che M, Chiao PJ, Abbruzzese JL, Sarkar FH. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int J Cancer. 2007b;120:906–917. - PubMed
    1. Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008;269:226–242. - PMC - PubMed
    1. Bektas N, Haaf A, Veeck J, Wild PJ, Luscher-Firzlaff J, Hartmann A, Knuchel R, Dahl E. Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer. BMC Cancer. 2008;8:1–9. - PMC - PubMed

Publication types

MeSH terms